NanoMedical Systems Receives $3M Grant to Advance nStrada™ Implantable Nanofluidics System for Long-Term Treatment of Opioid Use Disorder AUSTIN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- NanoMedical Systems, Inc. (NMS), an Austin-based company developing implantable, sustained-release, drug-delivery devices based on its nStrada™...